DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy Study of IV Fluids Only vs Ondansetron to Treat Dehydration

Information source: Children's Hospitals and Clinics of Minnesota
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Dehydration; Gastroenteritis

Intervention: Ondansetron (Drug); Saline (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Children's Hospitals and Clinics of Minnesota

Official(s) and/or principal investigator(s):
Sam Reid, MD, Principal Investigator, Affiliation: Children's Hospitals and Clinics of Minnesota
Henry Ortega, MD, Principal Investigator, Affiliation: Children's Hospitals and Clinics of Minnesota
Jeffrey Louie, MD, Principal Investigator, Affiliation: Children's Hospitals and Clinics of Minnesota

Overall contact:
Laurie Blumberg-Romero, Phone: 612-813-7628, Email: laurie.blumberg-romero@childrensmn.org

Summary

Dehydration due to vomiting is a common complication of acute gastroenteritis in children. Persistent vomiting following rehydration is a problem in outpatient management using oral rehydration therapy.

Four previous studies have examined the role of the medication, ondansetron, in treating nausea and vomiting in children with gastroenteritis and have suggested that it may be beneficial [1-4]. A previous study has also shown that the administration of intravenous fluid alone to children with dehydration due to gastroenteritis helps resolve nausea and vomiting in the majority of patients [5]. None of the previous studies compared the efficacy of intravenous ondansetron with that of intravenous fluid alone in the prevention of vomiting . In addition, the previous studies were limited by poorly defined inclusion criteria and outcome measures.

The proposed study seeks to more clearly define the role of intravenous ondansetron in the management of children suffering dehydration due to acute gastroenteritis. If ondansetron further reduces the incidence of vomiting compared with intravenous fluid alone, more children with dehydration due to acute gastroenteritis may be successfully discharged to home from the emergency department instead of admitted to the hospital. If it does not, the widespread use of ondansetron for such patients could be discouraged and money could be saved.

Hypothesis:

Patients receiving ondansetron in addition to intravenous fluids for the treatment of dehydration due to vomiting caused by gastroenteritis will not have a significant reduction in the occurrence of persistent vomiting as compared to those who receive only intravenous fluids.

Clinical Details

Official title: Ondansetron vs. Placebo in the Management of Children With Dehydration Due to Acute Gastroenteritis

Study design: Treatment, Randomized, Double Blind (Subject, Investigator), Parallel Assignment, Efficacy Study

Primary outcome: Received further IV fluids

Eligibility

Minimum age: 6 Months. Maximum age: 5 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age 6 months - 5 years

- Clinical diagnosis of acute gastroenteritis

- Mild or moderate dehydration as determined by validated clinical scale

- Clinical assessment to begin IV fluids

- Vomiting ≥ 2 episodes in past 4 hours

Exclusion Criteria:

- Severe dehydration

- History of significant gastrointestinal, metabolic, renal or cardiac disorder

- Ondansetron allergy

- Non-English language proficient parent/guardian

- Parent/guardian has no telephone

Locations and Contacts

Laurie Blumberg-Romero, Phone: 612-813-7628, Email: laurie.blumberg-romero@childrensmn.org

Children's Hospitals and Clinics of Minnesota, St. Paul, Minnesota 55102, United States; Recruiting
Sam Reid, MD, Phone: 651-220-6914, Email: sam.reid@childrensmn.org
Additional Information

Related publications:

Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006 Apr 20;354(16):1698-705.

Reeves JJ, Shannon MW, Fleisher GR. Ondansetron decreases vomiting associated with acute gastroenteritis: a randomized, controlled trial. Pediatrics. 2002 Apr;109(4):e62.

Ramsook C, Sahagun-Carreon I, Kozinetz CA, Moro-Sutherland D. A randomized clinical trial comparing oral ondansetron with placebo in children with vomiting from acute gastroenteritis. Ann Emerg Med. 2002 Apr;39(4):397-403.

Stork CM, Brown KM, Reilly TH, Secreti L, Brown LH. Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone in children. Acad Emerg Med. 2006 Oct;13(10):1027-33. Epub 2006 Aug 10.

Reid SR, Bonadio WA. Outpatient rapid intravenous rehydration to correct dehydration and resolve vomiting in children with acute gastroenteritis. Ann Emerg Med. 1996 Sep;28(3):318-23.

Starting date: September 2008
Ending date: September 2009
Last updated: March 19, 2009

Page last updated: October 19, 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012